KIORA PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense
KIORA PHARMACEUTICALS, INC. (KPRX) reported Increase (Decrease) in Prepaid Expense of -$342.03 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2022-11-09
- KIORA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense for the quarter ending 2022-09-30 was -$1.18M.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense for the quarter ending 2022-06-30 was $514.70K, a 148.30% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense for the quarter ending 2022-03-31 was $323.82K.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in prepaid expense for the quarter ending 2021-09-30 was -$99.15K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month |
|---|---|---|---|
| 2022-09-30 | -$1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$665.85K derived: sum of 2 quarters · filed 2022-11-09 | -$342.03K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $514.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $838.53K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $323.82K 10-Q · filed 2022-07-08 | ||
| 2021-09-30 | -$99.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $108.14K derived: sum of 2 quarters · filed 2022-11-09 | -$107.94K 10-Q · filed 2022-11-09 |
| 2021-06-30 | $207.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$8.79K 10-Q · filed 2022-08-12 | |
| 2021-03-31 | -$216.08K 10-Q · filed 2022-07-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |